Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-03-24

FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ABSORICA LD (isotretinoin) to update its labeling. The sponsor is Sun Pharmaceutical Industries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABSORICA LD (isotretinoin)

Snippet

SUPPL AP for ABSORICA LD (ISOTRETINOIN)